< Return to trials
Vulvovaginal Atrophy
Overview
Lillestol Research has trial experience in the vulvovaginal atrophy indication/diagnosis. Our research patient database also holds a multitude of patients with this diagnosis that would be interested in clinical trial participation.
Spotlight Trial(s)
This was an investigational product, placebo-controlled trial evaluating an IP on moderate to severe symptoms of vulvar and vaginal atrophy. Lillestol Research was able to successfully meet and exceed the sponsor’s enrollment expectation randomizing 8 patients in a 7-month enrollment period.